Delivery Order SPE2DR25D1100-SPE2DR26FCL2M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for OxyContin ER 40 mg tablets (100-count units) with a ceiling value of $1,754.92. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $5,399.46, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $2,098.96. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,675.65 on October 16, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units). The contract, which is not set-aside and utilizes firm fixed pricing, is scheduled for completion by October 17, 2025, with fulfillment from the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 22, 2025, for the supply of OxyContin ER 40 mg tablets (100-count packages) at a ceiling value of $8,696.13. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is scheduled for ultimate completion on May 23, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a contract value of $2,783.05. This delivery order represents a firm fixed price, non-set-aside competitive award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,932.66 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count bottles) with an ultimate completion date of July 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,561.94 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of OxyContin ER 40 mg tablets (100-count units). This is a firm fixed-price contract with an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL2MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of OxyContin ER 40 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $4,260.91. The delivery order was not set-aside and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical vendor with an extensive portfolio of federal contract awards, primarily with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for a controlled pharmaceutical product reflects the company's role in fulfilling specialized medical procurement requirements for the Department of Defense healthcare system with a completion target of October 30, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 10/29/25 |